Monday, November 20, 2017 11:32:28 AM
FDA-approved robot assistant gives surgeons force feedback
The agency has concluded that Senhance is as accurate as the da Vinci.
Surgeons are trained to accurately operate on you when you need it, but robotic assistants could help them get to hard-to-reach areas and boost their accuracy even more. Senhance, the robotic surgical assistant that has just earned the FDA's approval, was designed to accomplish both of those. The machine can help surgeons carry out minimally invasive surgery -- in fact, the FDA has approved its use because after a pilot test involving 150 patients, the agency has concluded that Senhance is as accurate as the da Vinci robot when it came to gynecological and colorectal procedures.
According to TransEnterix, the company that developed the machine, it's the first surgical assistant for the abdominal area to get the FDA's approval since 2000. The company claims it's also the first one with eye tracking and force feedback. As you can see above, surgeons sit behind a console with a 3D view of the site of operation to control three surgical arms. Senhance's camera can follow their eye movements and show what they'd be looking at if they were manually performing the surgery on screen. The machine's controllers can also make surgeons feel the stiffness of the tissue they're operating on.
Now that Senhance has been approved by the FDA, you'll likely start seeing it -- from afar, we hope, and not while you're on the operating table -- in hospitals across the US. Here's a sample procedure being performed with the machine's help if you'd like to watch it in action.
https://www.engadget.com/2017/10/15/fda-approves-senhance-robotic-surgical-assistant/
Recent ASXC News
- Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024 • GlobeNewswire Inc. • 05/07/2024 10:55:00 AM
- Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 04/29/2024 10:55:00 AM
- Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG • GlobeNewswire Inc. • 04/03/2024 12:45:00 PM
- Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023 • GlobeNewswire Inc. • 03/21/2024 08:05:00 PM
- U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor Declines • IH Market News • 03/21/2024 11:26:38 AM
- Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024 • GlobeNewswire Inc. • 03/15/2024 10:55:00 AM
- Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference • GlobeNewswire Inc. • 02/28/2024 11:55:00 AM
- Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals • GlobeNewswire Inc. • 02/27/2024 11:55:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 12:01:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 12:00:04 AM
- Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 01/16/2024 11:55:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 11:55:21 AM
- Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update • GlobeNewswire Inc. • 01/08/2024 11:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:45:21 PM
- Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System • GlobeNewswire Inc. • 01/04/2024 09:15:00 PM
- Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 11:55:00 AM
- Asensus Announces Sale of Senhance Robotic System in Romania • GlobeNewswire Inc. • 12/20/2023 11:55:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 11:26:08 PM
- Senhance Robotic System Sold by Asensus Surgical • GlobeNewswire Inc. • 12/04/2023 11:55:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:32 PM
- Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023 • GlobeNewswire Inc. • 11/14/2023 09:05:00 PM
- Asensus Surgical Announces Sale of Senhance Robotic System • GlobeNewswire Inc. • 11/14/2023 11:55:00 AM
- Asensus Surgical, Inc. Announces Agreement with Flex for Design and Advanced Manufacturing Services for the LUNA™ Surgical System • GlobeNewswire Inc. • 11/13/2023 09:15:00 PM
- Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 14, 2023 • GlobeNewswire Inc. • 11/07/2023 11:55:00 AM
- Asensus Surgical Announces Klinikum Idar-Oberstein Hospital in Germany to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 11/06/2023 11:55:00 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM